LY 353381: Clinical Trials

2 trials of LY 353381, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow LY 353381: new trials by email Literature Review of LY 353381 trials Research Report on LY 353381

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Arzoxifene to Treat Korean Women With Osteoporosis
arzoxifene, Placebo - Osteoporosis
Phase 2CompletedEli Lilly and Company912008-12-012015-04-30
LY353381 in Preventing Breast Cancer in Women With Hyperplasia
arzoxifene, Placebo - Breast Cancer
Phase 2CompletedUniversity of Kansas Medical Center1992000-08-012017-05-30

Conditions studied

Breast Neoplasms (1)  ·  Osteoporosis (1)

Sponsors

Eli Lilly and Company (1)  ·  University of Kansas Medical Center (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Carol J. Fabian, MD (1)

NIH funding

U01CA077165 (1)